These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 10547343)

  • 21. Targeting aberrant chromatin structure in colorectal carcinomas.
    Konishi K; Issa JP
    Cancer J; 2007; 13(1):49-55. PubMed ID: 17464246
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association between CpG island methylation and microsatellite instability in colorectal cancer.
    Ahuja N; Mohan AL; Li Q; Stolker JM; Herman JG; Hamilton SR; Baylin SB; Issa JP
    Cancer Res; 1997 Aug; 57(16):3370-4. PubMed ID: 9269998
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Correlations of CpG island methylator phenotype and OPCML gene methylation to carcinogenesis of hepatocellular carcinoma].
    Liu WJ; Wang L; Wang JP; Li JQ; Zhang CQ; Zheng L; Yuan YF
    Ai Zheng; 2006 Jun; 25(6):696-700. PubMed ID: 16764763
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of DNA from human stools to detect aberrant CpG island methylation of genes implicated in colorectal cancer.
    Belshaw NJ; Elliott GO; Williams EA; Bradburn DM; Mills SJ; Mathers JC; Johnson IT
    Cancer Epidemiol Biomarkers Prev; 2004 Sep; 13(9):1495-501. PubMed ID: 15342451
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic, epigenetic, and clinicopathologic features of gastric carcinomas with the CpG island methylator phenotype and an association with Epstein-Barr virus.
    Kusano M; Toyota M; Suzuki H; Akino K; Aoki F; Fujita M; Hosokawa M; Shinomura Y; Imai K; Tokino T
    Cancer; 2006 Apr; 106(7):1467-79. PubMed ID: 16518809
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epigenetic changes in solid and hematopoietic tumors.
    Toyota M; Issa JP
    Semin Oncol; 2005 Oct; 32(5):521-30. PubMed ID: 16210093
    [TBL] [Abstract][Full Text] [Related]  

  • 27. DNA methylation differences associated with tumor tissues identified by genome scanning analysis.
    Liang G; Salem CE; Yu MC; Nguyen HD; Gonzales FA; Nguyen TT; Nichols PW; Jones PA
    Genomics; 1998 Nov; 53(3):260-8. PubMed ID: 9799591
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alterations of DNA methylation associated with abnormalities of DNA methyltransferases in human cancers during transition from a precancerous to a malignant state.
    Kanai Y; Hirohashi S
    Carcinogenesis; 2007 Dec; 28(12):2434-42. PubMed ID: 17893234
    [TBL] [Abstract][Full Text] [Related]  

  • 29. General transcription factor binding at CpG islands in normal cells correlates with resistance to de novo DNA methylation in cancer cells.
    Gebhard C; Benner C; Ehrich M; Schwarzfischer L; Schilling E; Klug M; Dietmaier W; Thiede C; Holler E; Andreesen R; Rehli M
    Cancer Res; 2010 Feb; 70(4):1398-407. PubMed ID: 20145141
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CpG island methylator phenotype in colorectal cancer.
    Toyota M; Ahuja N; Ohe-Toyota M; Herman JG; Baylin SB; Issa JP
    Proc Natl Acad Sci U S A; 1999 Jul; 96(15):8681-6. PubMed ID: 10411935
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Polymorphisms in methyl-group metabolism genes and risk of sporadic colorectal cancer with relation to the CpG island methylator phenotype.
    Karpinski P; Myszka A; Ramsey D; Misiak B; Gil J; Laczmanska I; Grzebieniak Z; Sebzda T; Smigiel R; Stembalska A; Sasiadek MM
    Cancer Epidemiol; 2010 Jun; 34(3):338-44. PubMed ID: 20381446
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aberrant methylation in gastric cancer associated with the CpG island methylator phenotype.
    Toyota M; Ahuja N; Suzuki H; Itoh F; Ohe-Toyota M; Imai K; Baylin SB; Issa JP
    Cancer Res; 1999 Nov; 59(21):5438-42. PubMed ID: 10554013
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CpG island methylation of DNA damage response genes in advanced ovarian cancer.
    Teodoridis JM; Hall J; Marsh S; Kannall HD; Smyth C; Curto J; Siddiqui N; Gabra H; McLeod HL; Strathdee G; Brown R
    Cancer Res; 2005 Oct; 65(19):8961-7. PubMed ID: 16204069
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Aging and DNA methylation in colorectal mucosa and cancer.
    Ahuja N; Li Q; Mohan AL; Baylin SB; Issa JP
    Cancer Res; 1998 Dec; 58(23):5489-94. PubMed ID: 9850084
    [TBL] [Abstract][Full Text] [Related]  

  • 35. DNA methylation changes in cancer.
    Toyota M; Yamamoto E
    Prog Mol Biol Transl Sci; 2011; 101():447-57. PubMed ID: 21507361
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The CpG island methylator phenotype: what's in a name?
    Hughes LA; Melotte V; de Schrijver J; de Maat M; Smit VT; Bovée JV; French PJ; van den Brandt PA; Schouten LJ; de Meyer T; van Criekinge W; Ahuja N; Herman JG; Weijenberg MP; van Engeland M
    Cancer Res; 2013 Oct; 73(19):5858-68. PubMed ID: 23801749
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biological significance of the CpG island methylator phenotype.
    Suzuki H; Yamamoto E; Maruyama R; Niinuma T; Kai M
    Biochem Biophys Res Commun; 2014 Dec; 455(1-2):35-42. PubMed ID: 25016183
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The epigenetics of colorectal cancer.
    Issa JP
    Ann N Y Acad Sci; 2000 Jun; 910():140-53; discussion 153-5. PubMed ID: 10911911
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Methyltransferase expression and tumor suppressor gene methylation in sporadic and familial colorectal cancer.
    Joensuu EI; Nieminen TT; Lotsari JE; Pavicic W; Abdel-Rahman WM; Peltomäki P
    Genes Chromosomes Cancer; 2015 Dec; 54(12):776-87. PubMed ID: 26305882
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Concordant methylation of the ER and N33 genes in glioblastoma multiforme.
    Li Q; Jedlicka A; Ahuja N; Gibbons MC; Baylin SB; Burger PC; Issa JP
    Oncogene; 1998 Jun; 16(24):3197-202. PubMed ID: 9671399
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.